MedAssets, Inc

Company type	Public
Industry	Health Care Technology
Founded	1999
Fate	In the year 2016 was acquired by Pamplona Capital Management later merged with Equation now known as nThrive [1]
Headquarters	Alpharetta, Georgia
Key people	John Bardis (CEO)
Products	Revenue Cycle Management Accountable Care Management Spend and Clinical Resource Management Advisory Solutions Payor Solutions
Revenue	US$680.4 Million (FY 2013)[2]
Operating income	US$90.743 Million (FY 2013)[2]
Net income	US$27.441 Million (FY 2013)[2]
Total assets	US$1.613 Billion (FY 2013)[2]
Total equity	US$489.789 Million (FY 2013)[2]
Number of employees	3,400
Website	MedAssets

MedAssets, Inc. was an American healthcare performance improvement company. It provided products and services to 4,400 hospitals and 122,000 non-acute healthcare providers.^[3]

The Alpharetta, Georgia based company had 15 offices across the United States. States with a MedAssets location included California, Colorado, Georgia, New Jersey, Texas, and Washington.^[4]

In early 2016, MedAssets was split into two companies and was sold out. The company no longer exists in its original form, although some of its products exist under other brand names under various companies including nThrive (now FinThrive^[5]).

History

John Bardis founded MedAssets in June, 1999.^[6] The company began as a group purchasing organization (GPO) which offered its customers medical supply discounts. By August 2014, MedAssets had become the largest GPO in the United States.^[7] The company became publicly traded in 2007.^[8] MedAssets expanded its services over time and offerings included cost and clinical resource management, purchasing and revenue cycle solutions, change management consulting, and data-driven analytic software.^[9]

Acquisitions

• In 1999, MedAssets acquired the GPO InSource Health Services of Los Angeles, California (see 2001 acquisition note for reference)^{[citation needed]}
• In 2007, MedAssets acquired Xactimed^[10]
• In 2008, MedAssets acquired Accuro Healthcare Solutions^[11]
• In 2010, MedAssets acquired rival Broadlane^[11]
• In 2014, MedAssets acquired Sg2^[12]

References